FDA Drug recall D-0150-2024
Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc
- FDA Drug
- Class II
- terminated
- Published 2023-12-20
On 2023-12-20 the FDA classified a Class II recall of Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc by Sun Pharmaceutical Industries, citing failed Impurities/Degradation Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0150-2024 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2023-12-04 |
| Published | 2023-12-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sun Pharmaceutical Industries |
| Distribution | US |
Product
Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India. NDC 62756-589-88
Reason
Failed Impurities/Degradation Specifications
Identifiers
| ndc | 62756-589-83 |
|---|---|
| ndc | 62756-589-01 |
| ndc | 62756-589-88 |
| ndc | 62756-589-08 |
| ndc | 62756-589-18 |
| ndc | 62756-590-83 |
| ndc | 62756-590-01 |
| ndc | 62756-590-88 |
| ndc | 62756-590-08 |
| ndc | 62756-590-18 |
| ndc | 62756-591-83 |
| ndc | 62756-591-01 |
| ndc | 62756-591-88 |
| ndc | 62756-591-08 |
| ndc | 62756-591-18 |
| code_info | Lot DND0059A Expires 12/2023 Lot DND0060A Expires 12/2023 Lot DND0061A Expires 12/2023 Lot DND0062A Expires 01/2024 Lot…Lot DND0059A Expires 12/2023 Lot DND0060A Expires 12/2023 Lot DND0061A Expires 12/2023 Lot DND0062A Expires 01/2024 Lot DND0063A Expires 01/2024 Lot DND0064A Expires 01/2024 Lot DND0065A Expires 01/2024 Lot DND0180A Expires 01/2024 Lot DND0181A Expires 01/2024 Lot DND0182A Expires 01/2024 Lot DND0183A Expires 01/2024 Lot DND0184A Expires 01/2024 Lot DND0597A Expires 02/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0150-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.